To test our hypothesis, we utilized CD45.1 C57BL/6 mice as T cell donors to produce MigR control, Meso-CAR, and FAP-CAR T cells and adoptively transferred these cells via intravenous injection into CD45.2 C57BL/6 PDAC tumor-bearing hosts. Here, FAP is linked to neoplasm.